Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
filingDate |
2017-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50af1edf9f6d69812306ee1a36583d39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ebb0db6473b77d5c5b54ec9da1dd57b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f53c2e70a7d32f4016f3bf91d1bacee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ddb609b62579cd452253b39a54a4dd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75e0f654036d12f73865fc61ffd254a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad284368f6552afdd80216cd61098b12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1129603b7f55c11a7e6f09b87fc993c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0494b6fbb0a89118b57238d282b2b6fb |
publicationDate |
2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018305355-A1 |
titleOfInvention |
5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereof |
abstract |
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein. |
priorityDate |
2014-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |